Special Issue

Topic: The Latest Research Progress of Nonalcoholic Fatty Liver Disease

A Special Issue of Metabolism and Target Organ Damage

ISSN 2769-6375 (Online)

Submission deadline: 31 Oct 2023

Guest Editor(s)

Dr. Stefano Ballestri, MD, PhD
Internal Medicine Unit, Hospital of Pavullo, Azienda USL of Modena, Modena, Italy.

Special Issue Introduction

Nonalcoholic fatty liver disease (NAFLD), the most common cause of chronic liver disease worldwide, is a multisystem disease associated with hepatic and extrahepatic complications. NAFLD is strongly associated with an increased risk of fatal and nonfatal cardiovascular events. No standardized pharmacotherapy against NAFLD is available and several ongoing clinical trials are exploring new drugs. The Special Issue aims to highlight the most recent advances in the diagnosis and management of NAFLD. Potential topics to be discussed in this issue include new developments in:

● Disease definition; 

● Pathogenesis;

● Diagnosis and risk stratification;

● Anti-inflammatory, anti-metabolic, and anti-fibrotic therapies;

● Non-invasive markers of treatment efficacy;

● Management of lean vs. obese NAFLD.

Submission Deadline

31 Oct 2023

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/mtod/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=mtod&SpecialIssueId=mtod230424
Submission Deadline: 31 Oct 2023
Contacts: Leah Leah, Managing Editor, leah@oaemesas.com
                 

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/